Literature DB >> 10617155

Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosterone.

G Silvestrini1, P Ballanti, F R Patacchioli, P Mocetti, R Di Grezia, B M Wedard, L Angelucci, E Bonucci.   

Abstract

A connection has been suggested between glucocorticoid-induced osteopenia and an increase in the apoptosis of bone cells, and between the dimerization of the glucocorticoid receptor (GR) and the development of apoptosis. On this basis, a study has been carried out on the relationships between the occurrence of apoptotic cells and their detectable GR content, and between apoptosis frequency and changes in histomorphometric variables, in the growth plate and secondary spongiosa of rat long bones after the high-dose (10 mg/day) administration of corticosterone (CORT) and after recovery. The main results of the CORT treatment were: a significant increase in apoptotic osteoblasts, and a concomitant decrease in the histomorphometric variables of bone formation, with a reversal of both values during recovery; a nonsignificant increase in the apoptosis of osteoclasts, without changes in the histomorphometric variables of bone resorption; a significant increase in apoptotic terminal hypertrophic chondrocytes; the presence of GR in all types of skeletal cells in control rats, with different (cytoplasmic and/or nuclear) immunohistochemical detection in the same type of cell; a decrease in GR detection in proliferative chondrocytes and osteocytes in CORT and recovery groups, and in the maturative/hypertrophic chondrocytes of the recovery group; a fall in growth cartilage width, possibly due to the reduced proliferation of proliferative chondrocytes and increased apoptosis in terminal hypertrophic chondrocytes. In conclusion, pharmacological doses of CORT reduce bone formation by increasing osteoblast apoptosis; they reduce growth cartilage width, probably by inhibiting chondrocyte proliferation and increasing the apoptosis of terminal hypertrophic chondrocytes, and they reduce osteocyte GR. Although these effects appear to be mediated by the presence of GR in all skeletal cells, no precise correlation between GR immunohistochemical detection and apoptosis induction has been found.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617155     DOI: 10.1016/s8756-3282(99)00245-8

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  25 in total

Review 1.  Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts.

Authors:  John R Harrison; Henning W Woitge; Barbara E Kream
Journal:  Endocrine       Date:  2002-02       Impact factor: 3.633

2.  Poncirin prevents bone loss in glucocorticoid-induced osteoporosis in vivo and in vitro.

Authors:  Hyung-Young Yoon; Ye-Yeon Won; Yoon-Sok Chung
Journal:  J Bone Miner Metab       Date:  2012-03-13       Impact factor: 2.626

Review 3.  Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up.

Authors:  Alberto Roselló-Díez; Alexandra L Joyner
Journal:  Endocr Rev       Date:  2015-10-20       Impact factor: 19.871

Review 4.  Longitudinal growth in children following kidney transplantation: from conservative to pharmacological strategies.

Authors:  Tim Ulinski; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2006-05-10       Impact factor: 3.714

5.  Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs.

Authors:  Shojiro Akahoshi; Akinori Sakai; Shinobu Arita; Satoshi Ikeda; Yoshiomi Morishita; Hideki Tsutsumi; Masako Ito; Ayako Shiraishi; Toshitaka Nakamura
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

6.  Dexamethasone inhibits chondrocyte differentiation by suppression of Wnt/β-catenin signaling in the chondrogenic cell line ATDC5.

Authors:  Masako Naito; Akiko Ohashi; Tomihisa Takahashi
Journal:  Histochem Cell Biol       Date:  2015-06-24       Impact factor: 4.304

7.  Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation.

Authors:  Maobin Yang; Lorin B Trettel; Douglas J Adams; John R Harrison; Ernesto Canalis; Barbara E Kream
Journal:  Bone       Date:  2010-06-09       Impact factor: 4.398

8.  Effects of insulin-like growth factor-1 and dexamethasone on cytokine-challenged cartilage: relevance to post-traumatic osteoarthritis.

Authors:  Y Li; Y Wang; S Chubinskaya; B Schoeberl; E Florine; P Kopesky; A J Grodzinsky
Journal:  Osteoarthritis Cartilage       Date:  2014-11-11       Impact factor: 6.576

9.  Thyroid hormone, but not parathyroid hormone, partially restores glucocorticoid-induced growth retardation.

Authors:  Sylvia C van Buul-Offers; Jeske J Smink; Ria Gresnigt; Nicole Hamers; Joost Koedam; Marcel Karperien
Journal:  Pediatr Nephrol       Date:  2005-02-02       Impact factor: 3.714

10.  Towards understanding the dose and timing effect of hydrocortisone treatment on the scleral ossicle system within the chicken eye.

Authors:  Christine L Hammer; Tamara A Franz-Odendaal
Journal:  J Anat       Date:  2017-12-06       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.